.

Dr Lachlan Kelsey has been a member of the Vascular Engineering Laboratory (VascLab), which sits in the Cardiovascular Science and Diabetes Program at the Harry Perkins Institute of Medical Research, since graduating from his BEng (2013) and pursuing a PhD through UWA (2019). He is also Adjunct Research Fellow, at the UWA Centre for Medical Research.

As a postdoctoral team member at VascLab, Lachlan is involved in all computational projects there, acting in mentor and supervisory roles to junior team members (Hons, Masters and PhDs). Lachlan’s primary research focus is investigating coronary artery biomechanics, in which he uses multimodal imaging to develop new computational methods to better understand and treat coronary artery disease. This line of research has recently enabled the successful spin-out of Navier Medical Ltd, a company that is developing new software-based medical devices for patients with coronary heart disease. Dr Kelsey also led the technical R&D consulting work for Flomatrix Pty Ltd to design and patent a novel peripheral intravenous catheter that minimises device failure rates. Also, during the COVID-19 pandemic he worked as a member of the design team that developed TGA certified face shields with the Western Australian Department of Health.

In addition to research and translation, Lachlan created a curriculum of tutorials and workshops to introduce, and specialise, engineering students and medical researchers in the computational modelling methods used in vascular engineering. This is now embedded in the Master of Professional Engineering in Biomedical Engineering at UWA.

Lachlan feels lucky to work with so many talented engineers, scientists, and clinicians, and believes that our novel devices for cardiovascular disease treatment have the capacity to benefit both local and global health care systems.